Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9

Stem Cell Res. 2020 May:45:101784. doi: 10.1016/j.scr.2020.101784. Epub 2020 Apr 20.

Abstract

We report the engendering an isogenic iPSC line from the IBMS-iPSC-014-05 with homozygous correction of the R803X, Chr4: 88989098C > T in PKD2, using CRISPR/Cas9 technology. The results from the isogenic control, IBMS-iPSC-014-05C, showed that mutation had been corrected, while maintaining normal morphology, pluripotency, and differentiation capacity into three germ layers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Cell Differentiation
  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Humans
  • Induced Pluripotent Stem Cells*
  • Kidney